Skip to main content

Foster James C's Form 4 filing

Charles River Laboratories International, Inc. (CRL) · filed Aug 27, 2026

Accession no.
0001100682-26-000140
Filed
Aug 27, 2026, 4:21 PM ET
Trade date
Aug 25, 2026
Filing delay
2 days
Rule 10b5-1 plan
Checked

This filing lists 3 non-derivative transactions and 2 derivative transactions. Open-market sales total $10.1M. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Foster James CCIK 0001141722Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Aug 25, 2026Common StockMOption exerciseAcquired+21,132$194.12+$4,102,143.8452,728Direct
Aug 25, 2026Common StockMOption exerciseAcquired+12,429$208.44+$2,590,700.7665,157Direct
Aug 25, 2026Common StockSSaleDisposed−33,561$300.00−$10,068,30031,596Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Aug 25, 2026Common StockMOption exerciseDisposed−21,132$0.00$07,044Direct
Aug 25, 2026Common StockMOption exerciseDisposed−12,429$0.00$012,429Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)